Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era

• Autor(a) principal: Janeiro, Patrícia
• Data de Publicação: 2019
• Outros Autores: Jotta, Rita, Ramos, Ruben, Florindo, Cristina, Ventura, Fátima V., Vilarinho, Laura, Tavares de Almeida, Isabel, Gaspar, Ana
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.18/6652
• topic: Acyl-CoA Dehydrogenase; Acyl-CoA Dehydrogenase, Long-Chain; Amino Acid Metabolism, Inborn Errors; Cardiomyopathies; Carnitine; Carnitine O-Palmitoyltransferase; Child; Child, Preschool; Congenital Bone Marrow Failure Syndromes; Early Diagnosis; Female; Follow-Up Studies; Humans; Hyperammonemia; Hypoglycemia; Infant; Infant, Newborn; Lipid Metabolism, Inborn Errors; Male; Metabolism, Inborn Errors; Mitochondrial Diseases; Multiple Acyl Coenzyme A Dehydrogenase Deficiency; Muscular Diseases; Neonatal Screening; Prognosis; Retrospective Studies; Severity of Illness Index; Doenças Genéticas

Fatty acid β-oxidation (FAO) disorders have a wide variety of symptoms, not usually evident between episodes of acute decompensations. Cardiac involvement is frequent, and severe ventricular arrhythmias are suspected of causing sudden death. Expanded newborn screening (ENS) for these disorders, hopefully, contribute to prevent potentially acute life-threatening events. In order to characterize acute decompensations observed in FAO-deficient cases identified by ENS, a retrospective analysis was performed, covering a period of 9 years. Demographic data, number/type of acute decompensations, treatment, and follow-up were considered. Eighty-three clinical charts, including 66 medium-chain acyl-CoA dehydrogenase deficiency (MCADD), 5 carnitine-uptake deficiency (CUD), 3 carnitine palmitoyltransferase I and II (CPT I/II) deficiency, 5 very long-chain acyl-CoA dehydrogenase deficiency (VLCADD), and 4 multiple acyl-CoA dehydrogenase deficiency (MADD) cases were reviewed. Nineteen patients had acute decompensations (1 CPT I, 1 CPT II, 3 MADD, 14 MCADD). Six patients developed symptoms previously to ENS diagnosis. Severe clinical manifestations included multiple organ failure, liver failure, heart failure, and sudden death. Long-chain FAO disorders had the highest number of decompensations per patient. Conclusion: Despite earlier diagnosis by ENS, sudden deaths were not avoided and acute decompensations with severe clinical manifestations still occur as well.